Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas

Cancer Letters

Volumn 191, Issue 2, 2003, Pages 193-202

  Stolf, Beatriz S ^a,b   Carvalho, Alex F ^a   Martins, Waleska K ^a   Runza, Franco B ^a   Brun, Marcel ^b   Hirata Jr , Roberto ^b,c   Neves, Eduardo Jordão ^b   Soares, Fernando A ^d   Postigo Dias, Juan ^e   Kowalski, Luis P ^d   Reis, Luiz F L ^a,d  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c SENAC Coll of Comp Sci/Technology   (Brazil)

^d A C CAMARGO CANCER CENTER   (Brazil)

^e INSTITUTO NACIONAL DE ENFERMEDADES NEOPLÁSICAS   (Peru)

Author keywords

CDNA array; Differential display RT PCR; Goiter; Thyroid tumors; Tumor markers

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 5; TUMOR MARKER;

ARTICLE; CHROMOSOME 4; CHROMOSOME 7; CHROMOSOME MAP; CONTROLLED STUDY; EXPRESSED SEQUENCE TAG; FOLLICULAR CARCINOMA; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GOITER; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; THYROID ADENOMA; THYROID GLAND;

EID: 0037430644     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00679-1     Document Type: Article

References (40)

1. Shaha A.R. Controversies in the management of thyroid nodule. Laryngoscope. 110:2000;183-193.
2. Peter H.J., Gerber H., Studer H., Smeds S. Pathogenesis of heterogeneity in human multinodular goiter: a study on growth and function of thyroid tissue transplanted onto nude mice. J. Clin. Invest. 76:1985;1992-2002.
3. Sugenoya A., Masuda H., Komatsu M., Yokoyama S., Shimizu T., Fujimori M., Kobayashi S., Iida F. Adenomatous goitre: therapeutic strategy, postoperative outcome, and study of epidermal growth factor receptor. Br. J. Surg. 79:1992;404-406.
4. Pelizzo M.R., Piotto A., Rubello D., Casara D., Fassina A., Busnardo B. High prevalence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease. Tumori. 76:1990;255-257.
5. Koh K.B., Chang K.W. Carcinoma in multinodular goitre. Br. J. Surg. 79:1992;266-267.
6. Belfiore A., La Rosa G.L., La Porta G.A., Giuffrida D., Milazzo G., Lupo L., Regalbuto C., Vigneri R. Cancer risk in patients with cold thyroid nodules: relevance of iodine intake, sex, age, and multinodularity. Am. J. Med. 93:1992;363-369.
7. Wahner H.W., Cuello C., Correa P., Uribe L.F., Galtan E. Thyroid carcinoma in an endemic goiter area Cali, Colombia. Am. J. Med. 40:1966;58-66.
8. Balciri F., Djemli F.K., Mokrane L.A., Djidel F.K. The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma. Cancer. 82:1998;1146-1153.
9. Haraeh H.R., Willams E.D. Pathology of Thyroid Cancer. Wheeler M.H., Lazarus J.H. Diseases of the Thyroid. 1994;341-363 Chapman & Hall, London.
10. Maeda I., Takano T., Matsuzuka F., Maruyama T., Higashiyama T., Liu G., Kuma K., Amino N. Rapid screening of specific changes in mRNA in thyroid carcinomas by sequence specific-differential display: decreased expression of acid ceramidase mRNA in malignant and benign thyroid tumors. Int. J. Cancer. 81:1999;700-704.
11. Takano T., Miyauehi A., Yokozawa T., Matsuzuka F., Maeda I., Kuma K., Amino N. Preoperative diagnosis of thyroid papillary and anaplastie carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oneofetal fibroneetin messenger RNA. Cancer Res. 59:1999;4542-4545.
12. Grieco M., Santoro M., Berlingieri M.T., Melillo R.M., Donghi R., Bongarzone I., Pierotti M.A., Della P.G., Fusco A., Vecchio G. PTC is a novel rearranged form of the ret proto-oneogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell. 60:1990;557-563.
13. Said S., Schlumberger M., Suarez H.G. Oncogenes and anti-oncogenes in human epithelial thyroid tumors. J. Endoerinol. Invest. 17:1994;371-379.
14. Santoro M., Rosati R., Grieco M., Berlingieri M.T., D'Amato G.L., de F V., Fuseo A. The ret proto-oneogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene. 5:1990;1595-1598.
15. Takano T., Miyauchi A., Matsuzuka F., Liu G., Higashiyama T., Yokozawa T., Kuma K., Amino N. Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle used fix fine needle aspiration biopsy. J. Clin. Endocrinol. Metab. 84:1999;951-955.
16. Fuseo A., Grieeo M., Santoro M., Berlingieri M.T., Pilotti S., Pierotti M.A., Della P.G., Veeehio G. A new oncogene in human thyroid papillary carcinomas and their lymph- nodal metastases. Nature. 328:1987;170-172.
17. Santoro M., Carlomagno F., Romano A., Bottaro D.P., Dathan N.A., Grieco M., Fuseo A., Vecehio G., Matoskova B., Kraus M.H. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science. 267:1995;381-383.
18. van H. V, Genetics: one gene, four syndromes. Nature. 367:1994;319-320.
19. Silva A.M., Reis L.F. Sodium salicylate induces the expression of the immunophilin FKBP5 1 and biglycan genes and inhibits p34cdc2 mRNA both in vitro and in vivo. J. Biol. Chem. 275:2000;36388-36393.
20. Bieche I., Laurendeau I., Tozlu S., Olivi M., Vidaud D., Lidereau R., Vidaud M. Quantitation of MYC gene expression in sporadic breast tumors with a real-lime reverse transcription-PCR assay. Cancer Res. 59:1999;2759-2765.
21. Quinlan J.R. The Morgan Kaufinann Series in Machine Learning. The Morgan Kaufinann Series in Machine Learning. 1992;Morgan Kaufinann.
22. Breiman L., Friedman J.H., Olshen R.A., Stone C.J. The Wadsworth Statistics/Probability Series. The Wadsworth Statistics/Probability Series. 1984;Wadsworth International Group.
23. Abtschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
24. Zar J.H. Biostatistical Analysis. 2002;Prentice Hall.
25. Yu H., Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. 92:2000;1472-1489.
26. Holly J.M. Still more questions than answers: report on the 5th International Symposium on Insulin-bike Growth Factors, Brighton, UK, 31 October-4 November 1999. Trends Endocrinol. Metab. 11:2000;151-153.
27. Schneider M.R., Wolf E., Hoeflich A., Lahm H. IGF-binding protein-5: flexible player in the IGF system and effector on its own. J. Endocrinol. 172:2002;423-440.
28. Miyakoshi N., Richman C., Kasukawa Y., Linkhart T.A., Baylink D.J., Mohan S. Evidence that IGF-binding protein-5 functions as a growth factor. J. Clin. Invest. 107:2001;73-81.
29. Richman C., Baylink D.J., Lang K., Dony C., Mohan S. Recombinant human insulin-like growth factor-binding protein-S stimulates bone formation parameters in vitro and in vivo. Endocrinology. 140:1999;4699-4705.
30. Slootweg M.C., Ohlsson C., van EIk E.J., Netelenbos J.C., Andress D.L. Growth hormone receptor activity is stimulated by insulin-like growth factor binding protein 5 in rat osteosarcoma cells. Growth Regub. 6:1996;238-246.
31. Miyake H., Nebson C., Rennie P.S., Gleave M.E. Overexpression of insulin-bike growth factor binding protein-S helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3′-kinase pathway. Endocrinology. 141:2000;2257-2265.
32. Tennant M.K., Thrasher J.B., Twomey P.A., Birnbaum R.S., Plymate S.R. Insulin-like growth factor-binding proteins (IGFBP)-4, -5, and -6 in the benign and malignant human prostate: IGFBP-5 messenger ribonucleic acid localization differs from IGFBP-5 protein localization. J. Clin. Endocrinol. Metab. 81:1996;3783-3792.
33. Perks C.M., Bowen S., Gibl Z.P., Newcomb P.V., Holby J.M. Differential IGF-independent effects of insulin-like growth factor binding proteins (1-6) on apoptosis of breast epithelial cells. J. Cell Biochem. 75:1999;652-664.
34. Perks C.M., McCaig C., Hobby J.M. Differential insulin-bike growth factor (IGF)-independent interactions of IGF binding protein-3 and IGF binding protein-S on apoptosis in human breast cancer cells; involvement of the mitochondria. J. Cell Biochem. 80:2000;248-258.
35. Rozen F., Polbak M. Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB 1089 in MCF-7 breast cancer cells: a role for insulin-bike growth factor binding proteins. Int. J. Oncol. 15:1999;589-594.
36. Liang P., Pardee A.B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 257:1992;967-971.
37. Wan J.S., Sharp S.J., Poirier G.M., Wagaman P.C., Chambers J., Pyati J., Hom Y.L., Galindo J.E., Huvar A., Peterson P.A., Jackson M.R., Erbander M.G. Cloning differentially expressed mRNAs. Nat. Biotechnol. 14:1996;1685-1691.
38. Alizadeh A.A., Ross D.T., Perou C.M., van de R.M. Towards a novel classification of human malignancies based on gene expression patterns. J. Pathol. 195:2001;41-52.
39. Kallioniemi O.P. Biochip technologies in cancer research. Ann. Med. 33:2001;142-147.
40. Bartolazzi A. Improving accuracy of cytology for nodular thyroid lesions. Lancet. 355:2000;1661-1662.